Skip to main content
. 2013 Jul 17;2013(7):CD004185. doi: 10.1002/14651858.CD004185.pub3

Shen 2005.

Methods Randomised double‐blind, multicentre trial
Participants Patients with depressive disorder
Interventions Fluoxetine: 113 participants
Reboxetine: 109 participants
Fluoxetine dose: 20 mg/day
Reboxetine dose: 8 mg/day
Outcomes Hamilton Depression Rating Scale‐17 item (HDRS‐17), Hamilton Rating Scale for Anxiety (HAM‐A), Clinical Global Impression (CGI)
Notes Waiting for translation from Chinese to English (only abstract available in English)